Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-15
Biography and Research Information
OverviewAI-generated summary
Mason McCrury's research focuses on cancer-related molecular mechanisms, particularly investigating therapeutic targets and regulators of oncogenic pathways in lymphomas and non-small cell lung carcinoma. His work has explored the role of NEK2 as a therapeutic target in lymphoma and has investigated novel approaches to target oncogenes, such as using small molecules to inhibit G-quadruplex structures in the CARD11 oncogene promoter. McCrury has also contributed to understanding DNA structures, including G-quadruplex and i-motif formations in the promoter of the MYD88 gene, and the function of Rev1 in disrupting G-quadruplexes and stimulating translesion DNA synthesis. His publications include studies on bifunctional inhibitors and the conservation of protein motifs involved in DNA synthesis and repair. McCrury has a significant publication record with 59 total publications and a h-index of 3, with considerable collaboration with researchers at the University of Arkansas for Medical Sciences, including Kennith Swafford, Vijay Patel, Ying-Zhi Xu, and Sydnye L. Shuttleworth.
Metrics
- h-index: 3
- Publications: 59
- Citations: 34
Selected Publications
-
Human REV1 interacts with DHX36 to promote replication and tolerance of G-quadruplex DNA (2026)
-
DNA secondary structures in <i>BCL2</i> and <i>MYC</i> elicit activation-induced cytidine deaminase binding and activity (2026)
-
G-quadruplex and i-motif DNA structures form in the promoter of the key innate immune adaptor MYD88 (2025)
Collaboration Network
Top Collaborators
Kennith Swafford
University of Arkansas for Medical Sciences
3 shared publications
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
- G-quadruplex and i-motif DNA structures form in the promoter of the key innate immune adaptor MYD88
Samantha Kendrick
University of Arkansas for Medical Sciences
3 shared publications
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
- G-quadruplex and i-motif DNA structures form in the promoter of the key innate immune adaptor MYD88
Baku Acharya
University of Arkansas for Medical Sciences
2 shared publications
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
Ying-Zhi Xu
University of Arkansas for Medical Sciences
2 shared publications
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
Debasmita Saha
University of Arkansas for Medical Sciences (US)
2 shared publications
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
Brendan Frett
University of Arkansas for Medical Sciences
2 shared publications
In database
- Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
Thomas Raney
University of Arkansas for Medical Sciences
1 shared publication
In database
- Targeting a Novel G-Quadruplex in the CARD11 Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group
Amit Ketkar
University of Arkansas for Medical Sciences
1 shared publication
In database
- Conservation of the insert-2 motif confers Rev1 from different species with an ability to disrupt G-quadruplexes and stimulate translesion DNA synthesis
Reham S. Sewilam
University of Arkansas for Medical Sciences
1 shared publication
In database
- Conservation of the insert-2 motif confers Rev1 from different species with an ability to disrupt G-quadruplexes and stimulate translesion DNA synthesis
Jennifer Hall
University of Arkansas for Medical Sciences
1 shared publication
In database
- Conservation of the insert-2 motif confers Rev1 from different species with an ability to disrupt G-quadruplexes and stimulate translesion DNA synthesis
Ashtyn Bell
University of Arkansas for Medical Sciences
1 shared publication
In database
- Conservation of the insert-2 motif confers Rev1 from different species with an ability to disrupt G-quadruplexes and stimulate translesion DNA synthesis
Bethany C. Paxton
University of Arkansas for Medical Sciences
1 shared publication
In database
- Conservation of the insert-2 motif confers Rev1 from different species with an ability to disrupt G-quadruplexes and stimulate translesion DNA synthesis
Shreyam Tripathi
1 shared publication
- Conservation of the insert-2 motif confers Rev1 from different species with an ability to disrupt G-quadruplexes and stimulate translesion DNA synthesis
Julie Gunderson
Conway School of Landscape Design
1 shared publication
In database
- Conservation of the insert-2 motif confers Rev1 from different species with an ability to disrupt G-quadruplexes and stimulate translesion DNA synthesis
Robert L. Eoff
University of Arkansas for Medical Sciences
1 shared publication
In database
- Conservation of the insert-2 motif confers Rev1 from different species with an ability to disrupt G-quadruplexes and stimulate translesion DNA synthesis
Similar Researchers
Based on overlapping research topics
Kennith Swafford
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Lymphoma Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Reham S. Sewilam
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Drug Transport and Resistance Mechanisms
DNA Repair Mechanisms
Ying-Zhi Xu
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Lymphoma Diagnosis and Treatment
Drug Transport and Resistance Mechanisms
Trent R. Percy
University of Arkansas – Fort Smith
Cancer-related molecular mechanisms research
Lung Cancer Diagnosis and Treatment
Receptor Mechanisms and Signaling
Vijay Patel
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Lymphoma Diagnosis and Treatment
Receptor Mechanisms and Signaling
Aya Alsabagh
Arkansas State University
Cancer-related molecular mechanisms research
Receptor Mechanisms and Signaling
Bioinformatics and Genomic Networks